Stereotactic Ablative Radiotherapy: 303 Clinical Trials, Page 1 of 31

1 2 3 4 5 10 15 20  Last Page »

Hide Studies Not Open or Pending

4

Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

Condition(s):NSCLC; NSCLC Stage IV; Oligometastatic Disease; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; EGF-R Positive Non-Small Cell Lung Cancer; NSCLC Stage IV Without EGFR/ALK Mutation; Non-Small Cell Adenocarcinoma; Non-Small Cell Squamous Lung Cancer; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor; Synchronous Metastases; Metachronous MetastasisLast Updated:January 16, 2024Recruiting

1 2 3 4 5 10 15 20  Last Page »

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.